CHIP-Hsc70 Complex Ubiquitinates Phosphorylated Tau and Enhances Cell Survival*

The microtubule-binding protein tau has been implicated in the neurofibrillary pathology of Alzheimer's disease. Within affected cells, ubiquitinated and hyperphosphorylated tau assembles into massive filamentous polymers. Eventually these tangle-bearing neurons die. The formation of neurofibrillary tangles closely parallels the progression and anatomic distribution of neuronal loss in Alzheimer's disease, suggesting that these lesions play a role in the disease pathogenesis. Mutations in the human tau gene cause autosomal dominant neurodegenerative disorders. These and other neurodegenerative conditions are also characterized by extensive neurofibrillary pathology. The mechanisms underlying tau-mediated neurotoxicity remain unclear; however, phosphorylated tau is a strong candidate for a toxic molecule, particularly those isoforms phosphorylated by the kinases glycogen synthase kinase 3β and Cdk5. Here we show that Alzheimer tau binds to Hsc70, and its phosphorylation is a recognition requirement for the addition of ubiquitin (Ub) by the E3 Ub ligase CHIP (carboxyl terminus of the Hsc70-interacting protein) and the E2 conjugating enzyme UbcH5B. Other E3 Ub ligases including parkin and Cbl failed to ubiquitinate phosphorylated tau. CHIP could rescue phosphorylated tau-induced cell death, and therefore the CHIP-Hsc70 complex may provide a new therapeutic target for the tauopathies.

[1]  K. Titani,et al.  Proline-directed and Non-proline-directed Phosphorylation of PHF-tau (*) , 1995, The Journal of Biological Chemistry.

[2]  Akihiko Takashima,et al.  Chaperones increase association of tau protein with microtubules , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[3]  T. Dawson,et al.  Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[4]  E. Mandelkow,et al.  The switch of tau protein to an Alzheimer‐like state includes the phosphorylation of two serine‐proline motifs upstream of the microtubule binding region. , 1992, The EMBO journal.

[5]  E. Mandelkow,et al.  The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease. , 1998, Molecular biology of the cell.

[6]  D. Selkoe,et al.  Tau Epitopes are Incorporated into a Range of Lesions in Alzheimer's Disease , 1987, Journal of neuropathology and experimental neurology.

[7]  Georg Auburger,et al.  The ubiquitin pathway in Parkinson's disease , 1998, Nature.

[8]  D. Cyr,et al.  The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation , 2000, Nature Cell Biology.

[9]  R. D. Williams,et al.  Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[10]  C. Warren Olanow,et al.  Altered Proteasomal Function in Sporadic Parkinson's Disease , 2003, Experimental Neurology.

[11]  G. Bloom,et al.  Molecular Interactions among Protein Phosphatase 2A, Tau, and Microtubules , 1999, The Journal of Biological Chemistry.

[12]  Harry T Orr,et al.  Mutation of the E6-AP Ubiquitin Ligase Reduces Nuclear Inclusion Frequency While Accelerating Polyglutamine-Induced Pathology in SCA1 Mice , 1999, Neuron.

[13]  R. Barker,et al.  Movement Disorders , 1994, Stereotactic and Functional Neurosurgery.

[14]  宁北芳,et al.  疟原虫var基因转换速率变化导致抗原变异[英]/Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .

[15]  P. Davies,et al.  Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. , 1992, The Journal of biological chemistry.

[16]  J. Trojanowski,et al.  A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. , 1991, Science.

[17]  E. Hol,et al.  Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death1 , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  D. Cyr,et al.  CHIP Is a U-box-dependent E3 Ubiquitin Ligase , 2001, The Journal of Biological Chemistry.

[19]  J. Trojanowski,et al.  Epitopes that span the tau molecule are shared with paired helical filaments , 1988, Neuron.

[20]  C. Patterson,et al.  Cooperation of a ubiquitin domain protein and an E3 ubiquitin ligase during chaperone/proteasome coupling , 2001, Current Biology.

[21]  M. Farrer,et al.  Complex interactions in Parkinson's disease: A two‐phased approach , 2003, Movement disorders : official journal of the Movement Disorder Society.

[22]  S. Minoshima,et al.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.

[23]  P. Lansbury,et al.  Neurodegeneration: new clues on inclusions. , 2000, Chemistry & biology.

[24]  D. Wilkin,et al.  Neuron , 2001, Brain Research.

[25]  K. Jellinger General aspects of neurodegeneration. , 2003, Journal of neural transmission. Supplementum.

[26]  T. Fath,et al.  Tau-Mediated Cytotoxicity in a Pseudohyperphosphorylation Model of Alzheimer's Disease , 2002, The Journal of Neuroscience.

[27]  Nobutaka Hattori,et al.  Ubiquitination of a New Form of α-Synuclein by Parkin from Human Brain: Implications for Parkinson's Disease , 2001, Science.

[28]  Y. Imai,et al.  Parkin Suppresses Unfolded Protein Stress-induced Cell Death through Its E3 Ubiquitin-protein Ligase Activity* , 2000, The Journal of Biological Chemistry.

[29]  G. Johnson,et al.  Tau protein in normal and Alzheimer's disease brain. , 1999, Journal of Alzheimer's disease : JAD.

[30]  Yuan Su,et al.  Rapid Dephosphorylation of τ in Heat‐Shocked Fetal Rat Cerebral Explants: Prevention and Hyperphosphorylation by Inhibitors of Protein Phosphatases PP1 and PP2A , 1995, Journal of neurochemistry.

[31]  Kazuyuki Takata,et al.  Cdk5 Is a Key Factor in Tau Aggregation and Tangle Formation In Vivo , 2003, Neuron.

[32]  Patrick R. Hof,et al.  Tau protein isoforms, phosphorylation and role in neurodegenerative disorders 1 1 These authors contributed equally to this work. , 2000, Brain Research Reviews.

[33]  D. Wazer,et al.  ErbB2 Degradation Mediated by the Co-chaperone Protein CHIP* , 2003, The Journal of Biological Chemistry.

[34]  G. Bloom,et al.  Regulation of the Phosphorylation State and Microtubule-Binding Activity of Tau by Protein Phosphatase 2A , 1996, Neuron.

[35]  K. Kosik,et al.  Competition for microtubule-binding with dual expression of tau missense and splice isoforms. , 2001, Molecular biology of the cell.

[36]  H. Band,et al.  The Cbl family of ubiquitin ligases: critical negative regulators of tyrosine kinase signaling in the immune system , 2002, Journal of leukocyte biology.

[37]  M. Mercken,et al.  Glycogen Synthase Kinase-3β Phosphorylates Protein Tau and Rescues the Axonopathy in the Central Nervous System of Human Four-repeat Tau Transgenic Mice* , 2000, The Journal of Biological Chemistry.

[38]  J. Wegiel,et al.  Regulation of phosphorylation of neuronal microtubule-associated proteins MAP1b and MAP2 by protein phosphatase-2A and -2B in rat brain , 2000, Brain Research.

[39]  René Hen,et al.  Decreased nuclear β‐catenin, tau hyperphosphorylation and neurodegeneration in GSK‐3β conditional transgenic mice , 2001 .

[40]  Shinsei Minoshima,et al.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase , 2000, Nature Genetics.

[41]  Keiji Tanaka,et al.  CHIP is a chaperone‐dependent E3 ligase that ubiquitylates unfolded protein , 2001, EMBO reports.

[42]  I. Dominguez,et al.  Role of glycogen synthase kinase 3 beta as a negative regulator of dorsoventral axis formation in Xenopus embryos. , 1995, Proceedings of the National Academy of Sciences of the United States of America.